International journal of hematology · 2008
Defects of FA/BRCA pathway in lymphoma cell lines.
СтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Xiao Hui, Zhang Ke Jian, Xia Bing
Аннотация
The aim was to find the possible relationship between defects in the FA/BRCA pathway of genomic maintenance and potential pathogenesis of T and B cell lymphoma. We screened 29 cell lines derived from diverse subtypes of lymphoma for possible FA pathway defects. The results indicated: no defect in FANCD2 ubiquitination, BRCA2 and FANCJ expression; absence of FANCN protein in three cell lines: HT, Sudhl4 and JEKO-1. This absence was correlated with enhanced MMC-induced G2 arrest, growth inhibition and high chromosomal breakage rate in the three cell lines. We only found one substitution in HT and JEKO-1 exon-5a fragment: c.1769C > T, p. A590V. But in another lymphoma cell line Sudhl4 with FANCN absence, we have not found any mutation. In conclusion, this mutation maybe the reason which caused FANCN protein expression absent or made the protein very unstable and lose its function in HT and JEKO-1 cell lines.
Предметные рубрики MeSH
Apoptosis Regulatory ProteinsBRCA2 ProteinBasic-Leucine Zipper Transcription FactorsCell Line, TumorExonsFanconi Anemia Complementation Group D2 ProteinFanconi Anemia Complementation Group N ProteinFanconi Anemia Complementation Group ProteinsG2 PhaseGene Expression Regulation, NeoplasticHumansLymphoma, B-CellLymphoma, T-CellMutation, MissenseNuclear ProteinsSignal TransductionTumor Suppressor Proteins